Close X
Wednesday, November 27, 2024
ADVT 
National

Doctors push for faster second doses

Darpan News Desk The Canadian Press, 27 May, 2021 03:55 PM
  • Doctors push for faster second doses

Vaccine experts and infectious disease specialists are urging provinces to move faster to start getting second doses into arms in Canada, particularly for seniors and people with high-risk health conditions.

 "We definitely need to get a move on," said Dr. David Naylor, co-chair of the national immunity task force, in an interview with The Canadian Press.

 "I think there are compelling reasons to be picking up the pace on second doses."

 Almost 20.5 million Canadians have received at least their first dose as of Thursday, but fewer than two million of those have been fully vaccinated with both required doses.

 Canada delayed second doses up to 16 weeks in March, on the advice of the National Advisory Committee on Immunization, because vaccine supplies were so scarce.

 The strategy has worked to a point, with more than half of Canadians now having at least one shot, and evidence from the United Kingdom that delaying Pfizer-BioNTech and Oxford-AstraZeneca 12 weeks produced stronger immune responses in the end.

 While most provinces are setting their own vaccine markers for reopening the economy, chief public health officer Dr. Theresa Tam wants one-fifth of eligible Canadians to have both doses, and 75 per cent to have at least one, before provinces consider loosening restrictions on outdoor activities.

 Canada is likely to get to 75 per cent with one dose by June 21, but one-fifth with two doses is harder to gauge. Canada would have to triple the number of second doses it gives every day, immediately, to get there by Canada Day.

 Second doses are slowly increasing. Even a week ago, fewer than one in 10 shots given went to a second dose. In the last two days it has exceeded 15 per cent.

 But it's not fast enough for some.

 Naylor cited a new study from Public Health England this week which showed two doses of Pfizer-BioNTech or Oxford-AstraZeneca were two or three times as effective than just one dose at preventing a symptomatic infection of COVID-19 from two common variants, B.1.1.7 and B. 1.617.2.

 He said there isn't data yet that shows how sick people were getting if infected after one dose, which will make a difference in how troublesome the news is to Canada.

 Naylor also said seniors who have been waiting the longest for their second dose, who have been the most cautious about their activities and warned their immune systems aren't as strong after just one dose, also deserve to have their second appointments moved up.

MORE National ARTICLES

Singh calls for halt on arms sales to Israel

Singh calls for halt on arms sales to Israel
 Prime Minister Justin Trudeau responded by asking all sides to protect civilians and end the violence, saying rocket attacks against Israel as well as violence at an iconic mosque are "unacceptable."

Singh calls for halt on arms sales to Israel

Forces see little progress in drive to add women

Forces see little progress in drive to add women
Then-defence chief general Jonathan Vance in February 2016 set a goal of having women represent one-quarter of the Canadian Armed Forces' members over the next decade. At the time, women accounted for 15 per cent of military personnel.

Forces see little progress in drive to add women

Business leaders in U.S., Canada join Line 5 fight

Business leaders in U.S., Canada join Line 5 fight
The Canadian and U.S. chambers of commerce joined forces with their counterparts in Ohio, Michigan and Wisconsin by filing a joint brief in court to argue against Gov. Gretchen Whitmer's bid to shut down the cross-border pipeline.

Business leaders in U.S., Canada join Line 5 fight

Canada-U.S. spat over right whale prompts proposal

Canada-U.S. spat over right whale prompts proposal
A Canada-U.S. spat over who is responsible for the recent death of a critically endangered right whale has prompted a senior Canadian official to suggest there's got to be a better way of settling such disputes.

Canada-U.S. spat over right whale prompts proposal

Questions remain about AstraZeneca shot's future

Questions remain about AstraZeneca shot's future
Questions remained Wednesday about the future of the Oxford-AstraZeneca vaccine in Canada as the federal government prepared to receive hundreds of thousands of doses while provinces limited use of the shot.

Questions remain about AstraZeneca shot's future

600 COVID19 cases for Wednesday

600 COVID19 cases for Wednesday
British Columbia is now pausing the first dose AstraZeneca program. “Given the limited availability of the AstraZeneca vaccine supply, we are holding all remaining AstraZeneca vaccine for dose-two booster immunizations. Existing pharmacy bookings will proceed."

600 COVID19 cases for Wednesday